Z-2329-2021 Class II Terminated

Recalled by Howmedica Osteonics Corp. — Mahwah, NJ

FDA device recall Z-2329-2021 was initiated by Howmedica Osteonics Corp. on Jul 1, 2021 and is designated Class II. Reason for recall: The internal profile of the Triathlon Prim (Baseplate) is potentially oversized; there may be a witness mark (taper) at the bottom of the internal profile of the baseplate, which prevents the insert… The recall status is terminated (terminated May 17, 2023). Affected quantity: 14 US; 2 OUS.

Recall details

Product Type
Devices
Report Date
Aug 25, 2021
Initiation Date
Jul 1, 2021
Termination Date
May 17, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14 US; 2 OUS

Product description

Triathlon Prim CEM FXD BPLT 7, Catalog No. 5520B700

Reason for recall

The internal profile of the Triathlon Prim (Baseplate) is potentially oversized; there may be a witness mark (taper) at the bottom of the internal profile of the baseplate, which prevents the insert from locking on the baseplate.

Distribution pattern

Worldwide distribution - US Nationwide distribution in the states AR, CO, MN, MS, NJ, OK, PA, TX and the countries of China and Italy.

Code information

Lot JHS2H

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2329-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2329-2021. Report a data issue: hello@regdatalab.com.